What is Mendel?
Founded in 2016, Mendel operates at the intersection of artificial intelligence and clinical informatics. The company provides a sophisticated AI engine that automates the scanning and interpretation of unstructured patient data. By transforming fragmented medical records into actionable insights, Mendel enables healthcare providers to deliver highly personalized care plans. Its market position is defined by its ability to solve the 'data silo' problem in healthcare, positioning it as a critical infrastructure provider for modern medical institutions seeking to leverage machine learning for improved patient diagnostics and treatment efficacy.
How much funding has Mendel raised?
Mendel has raised a total of $42.1M across 3 funding rounds:
Other Financing Round
$2M
Debt
$150K
Series B
$40M
Other Financing Round (2017): $2M with participation from LaunchCapital, BootstrapLabs, SOSV, and DCM Ventures
Debt (2020): $150K led by PPP
Series B (2022): $40M supported by Oak HC/FT and DCM Limited
Key Investors in Mendel
Oak HC/FT
A premier venture growth-equity fund specializing in Healthcare Information and Services, focused on driving industry transformation through strategic counsel and board-level participation.
BootstrapLabs
A leading Silicon Valley venture capital firm dedicated to Applied Artificial Intelligence, providing early-stage capital and strategic advisory to mission-driven founders.
LaunchCapital
A venture capital firm that supports entrepreneurs at the seed and early stages, offering hands-on assistance and leveraging extensive family office networks.
What's next for Mendel?
With the recent influx of capital, Mendel is well-positioned to scale its operations and deepen its penetration into the enterprise healthcare market. The strategic focus will likely center on enhancing the predictive capabilities of its AI engine and expanding its footprint across major hospital networks. As the demand for data-driven clinical decision support grows, Mendel's ability to maintain high-fidelity data processing will be paramount. Investors are looking for the company to leverage this latest financing to solidify its competitive moat, potentially through expanded R&D initiatives and strategic partnerships that integrate its technology into existing electronic health record (EHR) workflows.
See full Mendel company page
